In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity
Simon Nannini, Celine Sieffert, Andrew McGown, Xin-Yue Gao et autres
0 citationsFigshare